Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: Elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1139-1146

  Broug Holub, Ellen ^a   Toews, Galen B ^b   Van Iwaarden, J Freek ^a   Strieter, Robert M ^b   Kunkel, Steven L ^b   Paine III, Robert ^b   Standiford, Theodore J ^b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL KILLING; CELL SURVIVAL; DATA ANALYSIS; IMMUNOREGULATION; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MORTALITY; PHAGOCYTE; PRIORITY JOURNAL;

EID: 0031004806     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.4.1139-1146.1997     Document Type: Article

References (55)

1. Appelberg, R. 1992. Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J. Leukocyte Biol. 52:303-307.
2. Bakker-Woudenberg, I. A. J. M., A. F. Lokerse, M. T. ten Kate, J. W. Mouton, M. C. Woodle, and G. Storm. 1993. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J. Infect. Dis. 168:164-171.
3. Baldwin, G. C., N. D. Fuller, R. L. Roberts, D. H. Ho, and D. W. Golde. 1989. Granulocyte- and granulocyte-macrophage colony stimulating factors enhance neutrophil cytotoxicity toward HIV-infected cells. Blood 74:1673-1677.
4. Berg, J. T., S. T. Lee, T. Thepen, C. Y. Lee, and M. F. Tsan. 1993. Depletion of alveolar macrophages by liposome-encapsulated dichloromethylene diphosphanate. J. Appl. Physiol. 74:2812-2819.
5. Cross, A. S., J. C. Sadoff, N. Kelly, E. Bernton, and P. Gemski. 1989. Pretreatment with recombinant murine tumor necrosis factor α/cachectin and murine interleukin 1α protects mice from lethal bacterial infection. J. Exp. Med. 169:2021-2027.
6. Dularay, B., C. J. Elson, S. Clements-Jewery, C. Damais, and D. Lando. 1990. Recombinant human interleukin-1 beta primes human polymorphonuclear leukocytes for stimulus-induced myeloperoxidase release. J. Leukocyte Biol. 47:158-163.
7. Ellis, M., S. Gupta, S. Galant, S. Hakim, C. VandeVen, C. Toy, and M. S. Cairo. 1988. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J. Infect. Dis. 158:1268-1276.
8. Feng, L., Y. Xia, T. Yoshimura, and C. B. Wilson. 1995. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 95:1009-1017.
9. Gordon, J. R., and S. J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor-α (TNF-α)/cachetin by mouse mast cells stimulated via the Fc RI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174:103-107.
10. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, L. L. Laichalk, D. C. McGillicuddy, and T. J. Standiford. 1996. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J. Infect. Dis. 173:159-165.
11. Hashimoto, S., J.-F. Pittet, K. Hong, H. Folkesson, G. Bagby, L. Kobzik, C. Frevert, K. Watanabe, S. Tsurufuji, and J. Wiener-Kronish. 1996. Depletion of alveolar macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections. Am. J. Physiol. 270:L819-L824.
12. Havell, E. A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894-2899.
13. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) by pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.
14. Kawabe, T., K. I. Isobe, Y. Hasegawa, I. Nakashima, and K. Shimokata. 1992. Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages. Immunology 76:72-78.
15. Kharazmi, A., H. Nielsen, C. Rechnitzer, and K. Bendtzen. 1989. Interleukin-6 primes human neutrophil and monocyte oxidative burst response. Immunol. Lett. 21:177-184.
16. Kips, J. C., J. H. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:332-336.
17. Laichalk, L. L., S. L. Kunkel, R. M. Stricter, J. M. Danforth, M. B. Bailie, and T. J. Standiford. 1996. Tumor necrosis factor mediates lung antibacterial host defense in murine Klebsiella pneumonia. Infect. Immun. 64:5211-5218.
18. McColm, A. A., E. Shelley, D. M. Ryan, and P. Acred. 1986. Evaluation of ceftazidime in experimental Klebsiella pneumoniae pneumonia: comparison with other antibiotics and measurement of its penetration into respiratory tissues and secretions. J. Antimicrob. Chemother. 18:599-608.
19. Ming, W. J., L. Bersani, and A. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138:1469-1474.
20. Monick, M., J. Glazier, and G. W. Hunninghake. 1987. Human alveolar macrophages suppress interleukin-1 activity via the secretion of prostaglandin E2. Am. J. Respir. Dis. 135:72-78.
21. Moser, R., B. Scheiffenbaum, P. Groscurth, and J. Fehr. 1989. Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J. Clin. Invest. 83:444-455.
22. Mulligan, M. S., A. A. Vaporciyan, M. Miyasaka, T. Tamatani, and P. A. Ward. 1993. Tumor necrosis factor regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142:1739-1744.
23. Mulligan, M. S., A. A. Vaporciyan, R. L. Warner, M. L. Jones, K. E. Foreman, M. Miyasaka, R. F. Todd III, and P. A. Ward. 1995. Compartmental ized roles for leukocytic adhesion molecules in lung inflammatory injury. J. Immunol. 154:1350-1363.
24. Nakane, A., T. Minagawa, and K. Kato. 1988. Endogenous tumor necrosis factor (cachetin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56:2563-2569.
25. Nathan, C. F. 1987. Secretory products of macrophages. J. Clin. Invest. 79:319-326.
26. Paine, R., III, M. W. Rolfe, T. J. Standiford, M. D. Burdick, B. J. Rollins, and R. M. Strieter. 1993. MCP-1 expression by rat alveolar type II cells in primary culture. J. Immunol. 150:4561-4570.
27. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483-1489.
28. Qian, Q., M. A. Jutila, N. Van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
29. Remick, D. G., R. M. Strieter, M. K. Eskandari, D. T. Nguyen, M. A. Genord, C. L. Raiford, and S. L. Kunkel. 1990. Role of tumour necrosis factor-a in lipopolysaccharide induced pathologic alterations. Am. J. Pathol. 136:49-60.
30. Rich, E. A., C. Cooper, Z. Toossi, M. L. Leonard, R. M. Stucky, R. T. Wiblin, and J. J. Ellner. 1991. Requirement for cell-to-cell contact for the immunosuppressive activity of human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 4:287-294.
31. Roilides, E., K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression by human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61:4870-4877.
32. Roth, M. D., and S. H. Golub. 1993. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta-1 to suppress lymphocyte activation. J. Leukocyte Biol. 53:366-371.
33. Schall, T. J. 1994. The chemokines, p. 419-460. In A. W. Thomson (ed.), The cytokine handbook, 2nd ed. Academic Press, San Diego, Calif.
34. Schmal, H., T. P. Shanley, M. L. Jones, H. P. Friedl, and P. A. Ward. 1996. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J. Immunol. 156:1963-1972.
35. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471-501.
36. Smart, S. J., and T. B. Casale. 1994. Pulmonary epithelial cells facilitate TNF-α-induced neutrophil chemotaxis. J. Immunol. 152:4087-4094.
37. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch III, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
38. Standiford, T. J., S. L. Kunkel, S. H. Phan, B. J. Rollins, and R. M. Strieter. 1991. Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J. Biol. Chem. 266:9912-9918.
39. Strieter, R. M., S. L. Kunkel, M. D. Burdick, P. M. Lincoln, and A. Walz. 1992. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21:589-596.
40. Strunk, R. C., D. M. Eidlen, and R. J. Mason. 1988. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin. Invest. 81:1419-1426.
41. Thepen, T., C. McMenamin, B. Girn, G. Kraal, and P. G. Holt. 1992. Regulation of IgE production in pre-sensitized animals: in vivo elimination of alveolar macrophages preferentially increases IgE responses to inhaled allergen. Clin. Exp. Allergy 22:1107-1114.
42. Thepen, T., C. McMenamin, J. Oliver, G. Kraal, and P. G. Holt. 1991. Regulation of immune response to inhaled antigen by alveolar macrophages: differential effects of in vivo alveolar macrophage elimination on the induction of tolerance vs immunity. Eur. J. Immunol. 21:2845-2850.
43. Thepen, T., N. van Rooijen, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170:499-509.
44. Tracey, K. J. 1994. Tumor necrosis factor-alpha, p. 289-304. In A. W. Thomson (ed.), The cytokine handbook. 2nd ed. Academic Press, San Diego, Calif.
45. Ulich, T. R., S. C. Howard, D. G. Remick, A. Wittwer, E. S. Yi, S. Yin, K. Guo, J. K. Welply, and J. H. Williams. 1995. Intratracheal administration of endotoxin and cytokines. VI. Antiserum to CINC inhibits acute inflammation. Am. J. Physiol. 268:L245-L250.
46. Ulich, T. R., S. C. Howard, D. G. Remick, E. S. Yi, T. Collins, K. Guo, S. Yin, J. L. Keene, J. J. Schumke, C. N. Steiniger, J. K. Welply, and J. H. Williams. 1994. Intratracheal administration of endotoxin and cytokines. VII. LPS induces E-selectin expression: anti-E-selectin and soluble-E-selectin inhibit acute inflammation. Inflammation 18:389-398.
47. Ulich, T. R., L. R. Watson, S. Yin, K. Guo, P. Wang, H. Thang, and J. del Castillo. 1991. The intratracheal instillation of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1, and TNF-induced inflammatory infiltrate. Am. J. Pathol. 138: 1485-1496.
48. Ulich, T. R., S. Yin, D. G. Remick, D. Russel, S. P. Eisenberg, and T. Kohno. 1993. The intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142:1335-1338.
49. VanOtteren, G. M., R. M. Strieter, S. L. Kunkel, R. Paine III, M. J. Greenberger, J. M. Danforth, M. D. Burdick, and T. J. Standiford. 1995. Compartmentalized expression of RANTES in a murine model of endotoxemia. J. Immunol. 154:1900-1908.
50. Van Rooijen, N. 1989. The liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods 124:1-6.
51. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1174:83-93.
52. Williams, D. M., D. M. Magee, L. F. Bonewald, J. G. Smith, C. A. Bleicker, G. I. Byrne, and J. Schacter. 1990. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 58:1572-1567.
53. Windsor, A. C. J., C. J. Walsh, P. G. Mullen, D. J. Cook, B. J. Fisher, C. R. Blocher, S. K. Leeper-Woodford, H. J. Sugerman, and A. A. Fowler III. 1993. Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J. Clin. Invest. 91:1459-1468.
54. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86:612-616.
55. Xing, Z., M. Jordana, H. Kirpalani, K. E. Driscoll, T. J. Schall, and J. Gauldie. 1994. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-α, macrophage inflammatory protein-2, interleukin-1β, and interleukin-6 but not RANTES or transforming growth factor-β1 mRNA expression in acute lung inflammation. Am. J. Respir. Cell Mol. Biol. 10:148-153.